Since 2013, TMCIGlobal has been providing accredited, online continuing medical education for healthcare professionals who want to learn about medical cannabis and its potential clinical application. We are so proud that 2023 marks our 10-year anniversary!
Available now!
In partnership with Futura Farms, based in Peru, TMCIGlobal is excited to announce the availability of three new patient case studies! These case studies, available in both English and Spanish, review medical cannabis use in patients with anxiety, insomnia, and chronic pain. We have also bundled these three patient case studies into one product at a discounted price!
Take a look now at our expanding course catalog and make sure you are signed up to receive our email notifications when new content is launched by using the Join Our Newsletter link in the footer below!
¡Disponible ahora!
En colaboración con Futura Farms, con sede en Perú, TMCIGlobal se complace en anunciar la disponibilidad de tres nuevos estudios de casos de pacientes. Estos estudios de caso, disponibles en inglés y español, revisan el uso de cannabis medicinal en pacientes con ansiedad, insomnio y dolor crónico. También hemos agrupado estos tres estudios de casos de pacientes en un solo producto a un precio con descuento.
Echa un vistazo ahora a nuestro catálogo de cursos en expansión y asegúrate de estar suscrito para recibir nuestras notificaciones por correo electrónico cuando se lance nuevo contenido utilizando el enlace Únete a nuestro boletín en el pie de página de abajo.
Bridging the Gap for Medical Professionals
The Medical Cannabis Institute (TMCIGlobal) aims to educate researchers seeking to gain a broader understanding of the medical use of cannabis. Since 2013, TMCIGlobal has provided accredited medical cannabis education to healthcare practitioners.
TMCIGlobal has provided cannabis education to knowledge seekers all across the United States, and in 34 countries across six continents. Through our site, learners have earned over 36,000 hours of continuing education credit.
TMCIGlobal’s faculty includes subject matter experts and leading medical professionals working together to develop the highest-quality medical cannabis education. We have expanded our content offerings in 2023 with new Spanish case studies regarding the use medical cannabis for anxiety and insomnia, with a new case study on medical cannabis use for chronic pain coming soon!
Recently Released Courses
Spanish Case Studies
TMCIGlobal and Futura Farms
In partnership with Futura Farms, based in Peru, TMCIGlobal has launched three patient case studies in both English and Spanish! These case studies review medical cannabis use in patients with anxiety, insomnia, and chronic pain. These cases are also available as a bundled product at a discounted price.
En colaboración con Futura Farms, con sede en Perú, TMCIGlobal ha lanzado tres estudios de casos de pacientes, ¡tanto en inglés como en español! Estos estudios de caso revisan el uso de cannabis medicinal en pacientes con ansiedad, insomnio y dolor crónico. Estas fundas también están disponibles en paquetes a un precio rebajado.
Certificate of Completion Available
$30.00
Maryland Provider Education: Medical Use of Cannabis v3.0
TMCIGlobal
Approved by the Maryland Medical Cannabis Commission, this course is designed for providers in the State of Maryland seeking to gain basic knowledge about the use of medical cannabis and to participate in the Maryland Medical Cannabis program.
CME/CE-Certified Activity and Resources
$179.00
Virginia State Medical Use of Cannabis v1.0
TMCIGlobal
This course provides practitioners in the State of Virginia with basic knowledge about the use of medical cannabis in order to assist patients who wish to use medical cannabis.
CME/CE-Certified Activity and Resources
$179.00
The Endocannabinoid System’s Role in Regulating Pain
“THC is able to relieve stress and pain to a certain extent [which] could help us devise … compounds [to] selectively boost the ability of the endocannabinoid system to regulate stress in the central nervous system and pain in the periphery. [This] is one of the most untapped and most fascinating areas of modern pharmacology.”
Daniele Piomelli, PhD
Professor of Anatomy, Neurobiology, Pharmacology and Biological Chemistry at the University of California, Irvine
Content Contributors
_________________________________________________________________________________
Scoping out recent scientific medical cannabis research!
Check here frequently to see new updates.
Balancing risks and benefits of cannabis on humans: umbrella review of meta-analyses of randomized controlled trials and observational studies.
The objective of this study was to systematically assess credibility/certainty of associations between cannabis/cannabinoids/cannabis-based medicines (CBM) and human health, from observational/ randomized controlled trials (RCTs).
Conclusions: Convincing or converging evidence prompts to avoid cannabis during adolescence and early adulthood, in people prone to/with mental disorders, in pregnancy and before/while driving. Cannabidiol is effective for epilepsy, notably in children, while CBM can be effective in multiple sclerosis, chronic pain, and palliative care, not without adverse events. This work informs individual risk/benefit considerations, knowledge translation efforts impacting policy making, and guidelines across different branches of medicine.
